Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

This publication has 26 references indexed in Scilit:

• Anti-preS2 neutralizes the hepatitis B virus variant with a vaccine-escape mutation at the amino acid position 126 or 145 within the S gene
  International Hepatology Communications, 1994
• Treatment of Clostridium difficile diarrhoea with brewer's yeast
  The Lancet, 1994
• New strategies for using mucosal vaccination to achieve more effective immunization
  Vaccine, 1994
• Induction and Assessment of Immunity at Enteromucosal Surfaces in Humans: Implications for Vaccine Development
  Clinical Infectious Diseases, 1993
• Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent
  Microbial Ecology in Health & Disease, 1993
• The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface
  Journal of General Virology, 1992
• Improved method for high efficiency transformation of intact yeast cells
  Nucleic Acids Research, 1992
• Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response
  Virus Research, 1992
• High-copy-number integration into the ribosomal DNA of Saccharomyces cerevisiae: a new vector for high-level expression
  Gene, 1989
• New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites
  Gene, 1988